Dr. Manana B. Elia, MD

Dr. Elia practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Dr. Elia's NPI, 1609841816, was assigned on February 21, 2006. Dr. Elia graduated from Tbilisi State Medical University in 1982. Dr. Elia holds California license C177706.

Dr. Elia's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (800) 826-4673.

Dr. Elia's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. The medical group on file is City of Hope. Dmand AI also links Dr. Elia to 1 more other site, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Elia practices. Vendor and product names are available with a free account.

Medical oncology is Dr. Elia's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Elia is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Elia's licenses on file in 4 states: California, Kansas, Missouri and Georgia.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, lung cancer and lymphoma among the conditions Dr. Elia treats.

CMS data shows 1,125 Medicare services from Dr. Elia across 7 procedure codes in 2024, for 269 Medicare patients. Medicare paid $98,491 for them.

CMS counts 269 Medicare patients who saw Dr. Elia in 2024. The largest group is 65 to 74, with 152 patients. 75% of them have cancer, and 72% have high cholesterol. 41% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Elia's median patient age at 66, with 98% women.

In 2024, Dr. Elia wrote 453 Medicare Part D claims for 115 patients. 85% of them were for generic drugs. CMS names the drug for 301 of them, across 14 drugs with 11 or more claims each, at $822,749 in total drug cost. In 2023, CMS named 223 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Elia for performance year 2024, reported as part of a group. Dr. Elia accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Elia as offering telehealth.

Dmand AI links 11 papers to Dr. Elia, published from 2014 to 2025. 2014 was the busiest year, with 2. The most frequent topics are Breast Neoplasms. Dr. Elia has published most often in NPJ Breast Cancer. Dr. Elia's most frequent co-authors are Anne P. O'Dea, MD, Shane Richard Stecklein, MD, PhD and Gregory James Crane, MD.

CMS Open Payments shows 30 general payments to Dr. Elia from 8 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 73% of the total. Gilead Sciences, Inc. paid the most, $5,521.

Dmand AI lists 1 award for Dr. Elia, most recently Summa Cum Laude in 1982.

Dr. Elia graduated from Tbilisi State Medical University in 1982.

Dr. Elia is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.